Bcl-2 Inhibitor II, YC137-CAS 810659-53-1-Calbiochem

C₂₄H₂₁N₃O₆S₂

511.57

A cell-permeable naphthoquinone compound that selectively induces apoptosis of Bcl-2-overexpressing cells (<300 nM in MDA-MB435B breast cancer cells) with little effect on a variety of primary cells, and Bcl-x_L-dependent cells, even at a concentration of 5 µM. Preferentially binds Bcl-2 (K_i = 1.3 µM) and disrupts its interaction with Bid BH3, thereby blocking the anti-apoptotic activity of Bcl-2. Shown to induce the release of cytochrome c from mitochondria and activate caspase-9.
A cell-permeable molecule that targets the BH3•domain interaction and selectively induces apoptosis in Bcl-2-overexpressing cells (<300 nM in MDA-MB435B breast cancer cells). Exhibits little effect on a variety of primary cells and Bcl-x_L-dependent cells, even at a concentrations as high as 5 µM. Inhibits the binding of Bid BH3 to Bcl-2 thereby blocking the anti-apoptotic activity of Bcl-2.

Cell permeable: yes
Product does not compete with ATP.
Reversible: no
Target K_i: 1.3 µM in binding Bcl-2

Toxicity: Carcinogenic / Teratogenic (D)

Real, P.J., et al. 2004. Cancer Res. 64, 7947.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

100

≥90% (HPLC)

solid

Calbiochem^®

OK to freeze
protect from light

red

DMSO: 5 mg/mL
ethanol: 5 mg/mL

wet ice

−20℃

5 mg in Glass bottle
Packaged under inert gas

11 - Combustible Solids

WGK 1